Cormedix (CRMD) Competitor Comparison
We are evaluating the key criteria listed to compare Cormedix (CRMD) against its competitors in the Biotechnology industry.
Market Capitalization
231 / 368Gross Profits
149 / 278Total Revenue
279 / 300EBITDA
130 / 337Free Cashflow
136 / 352Quick Ratio
64 / 357Earnings per Share
117 / 359Dividend yield
0 / 6Total Cash
227 / 358Performance 3 years
51 / 368Performance 5 years
106 / 368Performance 10 years
86 / 368Linearity 3 years
273 / 368Linearity 5 years
74 / 368Linearity 10 years
6 / 367Total Rank
93 / 368Dividend Rank
94 / 368Valuation Rank
295 / 368Piotroski Rank
101 / 368Muliplier Rank
317 / 368Market Capitalization - CRMD ranking 231 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.